Loading…

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2017-12, Vol.35 (4), p.914-917
Main Authors:	Pro, Barbara, Horwitz, Steven M., Prince, H. Miles, Foss, Francine M., Sokol, Lubomir, Greenwood, Matthew, Caballero, Dolores, Morschhauser, Franck, Wilhelm, Martin, Iyer, Swaminathan Padmanabhan, Shustov, Andrei R., Wolfson, Julie, Balser, Barbara E., Coiffier, Bertrand
Format:	Article
Language:	English
Subjects:	Aged Cancer Depsipeptides - administration & dosage Depsipeptides - adverse effects Disease-Free Survival Female Follow-Up Studies Hematology Human health and pathology Humans Letter to the Editor Letters to the Editor Life Sciences Lymphocytes T Lymphoma Lymphoma, T-Cell, Peripheral - drug therapy Lymphoma, T-Cell, Peripheral - mortality Male Middle Aged Pharmaceutical sciences Pharmacology Recurrence Survival Rate T-cell lymphoma
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!